The webinar, Principles and Considerations for Tumor Mutational Burden (TMB) hosted by The Pathologist and illumina is approaching on December 5, 2018 at 17.00 CET
Don’t miss on the opportunity to:
- Gain an understanding of the value of TMB in tailoring precision medicine.
- Learn about key requirements for a robust next-generation sequencing (NGS) panel to measure TMB.
- Hear first-hand insights from a clinical researcher using genomics in translational cancer research.
Register today to listen to:
Albrecht Stenzinger, M.D.
Head, Center for Molecular Pathology (CMP)
Head, Section for Biomarker Development and Molecular Diagnostics
Institute of Pathology Heidelberg (IPH), University Hospital Heidelberg
Albrecht will discuss the principles of using NGS to identify the number of genetic alterations in a tumor (called tumor mutational burden or TMB). As an early adopter for using TMB in translational cancer research, Dr. Stenzinger brings valuable insights and considerations for laboratories interested in implementing TMB measurement using NGS.
I hope you can join us for this webinar. Register now to secure your place.